MSD discontinues Stocrin and Isentriss

We have become aware that MSD has discontinued the following:

Stocrin (EFAVIRENZ) 200mg & 600mg

Isentriss Chewable (Raltegravir) 25mg & 100mg

People who were still taking these medications should consult their s100 prescriber for alternative options.

MSD notes “The decision to discontinue these brands is due to the very low volumes used in the Australian market” and “that there is no issue with the quality or safety of any existing stock that may be in use or available”.

icon-angle icon-bars icon-times